Table 1.
Demographic and Clinical Data of Patients With Multizonal Outer Retinopathy and Retinal Pigment Epitheliopathy (MORR)
| Characteristics | Number | |
| No. of patients | 10 | |
| No. of eyes | 20 | |
| Age at presentation (mean years ± SD, range) | 54.1 ± 13.3 (38–71) | |
| Follow-up duration (mean years ± SD, range) | 13.1 ± 5.3 (8–23) | |
| Gender n (%) | ||
| Male | 2/10 (20.0%) | |
| Female | 8/10 (80.0%) | |
| Ocular involvement at presentation | ||
| Bilateral | 10/10 (100%) | |
| Peripapillary lesion | 20/20 (100%) | |
| Additional midperipheral lesion | 3/20 (15%) | |
| Far-peripheral lesion | 20/20 (100%) | |
| BCVA in LogMAR (mean Snellen equivalent, range) | ||
| Initial | 0.18 (20/30, range 20/20–20/200) | |
| Final | 1.04 (20/214, range 20/20 to hand motion) | |
| Presenting symptoms n (%) | ||
| Scotoma | 17/20 (85.0%) | |
| Photopsia | 17/20 (85.0%) | |
| Asymptomatic | 3/20 (15.0%) | |
| Treatments n (%) | ||
| None | 7/10 (70.0%) | |
| Oral corticosteroid | 2/10 (20.0%) | |
| Immunosuppressive therapy | 2/10 (20.0%) | |
| Intravitreal corticosteroid | 2/10 (20.0%) | |
| Intravitreal bevacizumab | 1/10 (10.0%) | |
BCVA, best-corrected visual acuity; LogMAR, logarithm of the minimum angle of resolution.